Ford offers 'employee pricing for everyone' as tariffs send shockwaves through auto industryByBruce GilPublishedApril 3, 2025
Lululemon, Nike, and Deckers stocks are hit hard by Trump’s sweeping tariff planByBruce GilPublishedApril 3, 2025
Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug optionsByBruce GilPublishedApril 2, 2025
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slumpByBruce GilPublishedApril 2, 2025
Here's how much Ozempic and similar drugs have soared in popularity since 2018ByBruce GilPublishedApril 1, 2025
A Chinese brain chip company could soon surpass Elon Musk's NeuralinkByBruce GilPublishedApril 1, 2025
Moderna and other vaccine stocks fall after a top FDA official quitsByBruce GilPublishedMarch 31, 2025
Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approvalByBruce GilPublishedMarch 28, 2025
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundupByBruce GilPublishedMarch 28, 2025
